|
|
|
|
Social Rewards and Gray Matter: Why Are They Linked?
When people feel 'all warm and fuzzy' inside, say after being praised, they should perhaps thank their orbitofrontal cortex and nucleus accumbenstwo brain regions also involved in rewarding people for social interaction.Whether it is...
|
|
|
Genetic and Biochemical Characterization of the First Extended-Spectrum CARB-Type -Lactamase, RTG-4, from Aci
Acinetobacter baumannii isolate KAR was uncommonly more resistant to cefepime and cefpirome than to ceftazidime and cefotaxime.Cloning and expression of the -lactamase gene content of this isolate into Escherichia coli TOP10...
|
|
|
Rogue scientists: Hunt is on for cloning criminals
THE Federal Government is tendering for a team of private investigators to hunt rogue scientists or criminals who breach human anti-cloning laws.Federal health authorities have issued a tender for investigators to police its controversial...
|
|
|
Simple, Fast, and Efficient Cloning of PCR Products with TOPO® Cloning Vectors
Traditional restriction enzyme cloning methods are time-consuming and tedious, and with their relatively low efficiencies, multiple colonies must be screened to find the insert of interest.By removing laborious and unreliable steps from...
|
|
|
Cloning Ancient Trees
STAND TALL: A stand of old cypress trees that are around 500 years old provide a shade for visitors in the Temple of Heaven in Beijing (LU XIN) West of Tiananmen Square in Beijing, in Zhongshan Park, there stand several ancient cypress trees...
|
|
|
Gene Bridges Licenses Recombineering Technology to Chugai Pharmaceutical Co., Ltd
- Gene Bridges GmbH announced that Chugai Pharmaceutical Co., Ltd.of Tokyo, Japan has completed the amendment to expand the commercial license agreement existing since 2005 for the use of the Red/ET recombination technology from Gene...
|
|
|
EMBL spin-out extends deal with Japanese pharma
idges GmbH has announced thatCo., Ltd.of Tokyo, Japan, has expanded the commercial license agreement existing since 2005 for the use of its Red/ET recombination technology. The Red/ET recombination technology, patented in Japan under...
|
|
|
Gene Bridges Licenses Recombineering Technology to Chugai Pharmaceutical Co., Ltd
The Red/ET recombination technology, patented in Japan under the title 'Novel DNA Cloning Method, is a valued method for generating targeting vectors or modifying E.coli chromosomes. Red/ET is fast becoming the standard DNA...
|
|
|
Gene Bridges Licenses Recombineering Technology to Chugai Pharmaceutical Co., Ltd
Gene Bridges GmbH, the recombineering company, today announced that Chugai Pharmaceutical Co., Ltd.of Tokyo, Japan has completed the amendment to expand the commercial license agreement existing since 2005 for the use of the Red/ET...
|
|
|
Gene Bridges Licenses Recombineering Technology to Chugai Pharmaceutical Co., Ltd
- Gene Bridges GmbH, the recombineering company, today announced that Chugai Pharmaceutical Co., Ltd.of Tokyo, Japan has completed the amendment to expand the commercial license agreement existing since 2005 for the use of the Red/ET...
|
|
|
Gene Bridges Licenses Recombineering Technology to Chugai Pharmaceutical Co., Ltd
HEIDELBERG, Germany - (BUSINESS WIRE) - Gene Bridges GmbH, the recombineering company, today announced that Chugai Pharmaceutical Co., Ltd.of Tokyo, Japan has completed the amendment to expand the commercial license agreement existing...
|
|
|
Gene Bridges licenses Recombineering tech to Chugai
Germany's Gene Bridges has said Japan's Chugai Pharmaceuticals has licensed its Red/ET recombination technology.The Red/ET recombination technology, patented in Japan under the title 'Novel DNA Cloning Method, is a valued method for...
|
|
|
Gene Bridges Licenses Recombineering Technology to Chugai Pharmaceutical Co., Ltd
Gene Bridges GmbH, the recombineering company, today announced that Chugai Pharmaceutical Co., Ltd.of Tokyo, Japan has completed the amendment to expand the commercial license agreement existing since 2005 for the use of the Red/ET...
|
|
|
Gene Bridges Licenses Recombineering Technology to Chugai Pharmaceutical Co., Ltd
BusinessWire - Gene Bridges GmbH, the recombineering company, today announced that Chugai Pharmaceutical Co., Ltd.of Tokyo, Japan has completed the amendment to expand the commercial license agreement existing since 2005 for the use of...
|
|
|
Gene Bridges Licenses Recombineering Technology to Chugai Pharmaceutical Co., Ltd
HEIDELBERG, Germany--(BUSINESS WIRE)--Gene Bridges GmbH, the recombineering company, today announced that Chugai Pharmaceutical Co., Ltd.of Tokyo, Japan has completed the amendment to expand the commercial license agreement existing since...
|
|
|
Gene Bridges Licenses Recombineering Technology to Chugai Pharmaceutical
Gene Bridges GmbH, the recombineering company, today announced that Chugai Pharmaceutical Co., Ltd.of Tokyo, Japan has completed the amendment to expand the commercial license agreement existing since 2005 for the use of the Red/ET...
|
|
|
Gene Bridges Licenses Recombineering Technology to Chugai Pharmaceutical Co., Ltd
HEIDELBERG, Germany--(BUSINESS WIRE)--Gene Bridges GmbH, the recombineering company, today announced that Chugai Pharmaceutical Co., Ltd.of Tokyo, Japan has completed the amendment to expand the commercial license agreement existing since...
|
|
|
Gene Bridges Licenses Recombineering Technology to Chugai Pharmaceutical Co., Ltd
Gene Bridges GmbH, the recombineering company, today announced that Chugai Pharmaceutical Co., Ltd.of Tokyo, Japan has completed the amendment to expand the commercial license agreement existing since 2005 for the use of the Red/ET...
|
|
|
Gene Bridges Licenses Recombineering Technology to Chugai Pharmaceutical Co., Ltd
Gene Bridges GmbH, the recombineering company, today announced that Chugai Pharmaceutical Co., (News) Ltd.of Tokyo, Japan has completed the amendment to expand the commercial license agreement existing since 2005 for the use of the Red/ET...
|
|
|
Gene Bridges Licenses Recombineering Technology to Chugai Pharmaceutical Co., Ltd
HEIDELBERG, Germany--(BUSINESS WIRE)-- Gene Bridges GmbH, the recombineering company, today announced that Chugai Pharmaceutical Co., Ltd.of Tokyo, Japan has completed the amendment to expand the commercial license agreement existing...
|
|
|
Gene Bridges Licenses Recombineering Technology to Chugai Pharmaceutical Co., Ltd
HEIDELBERG, Germany--(BUSINESS WIRE)--Gene Bridges GmbH, the recombineering company, today announced that Chugai Pharmaceutical Co., Ltd.of Tokyo, Japan has completed the amendment to expand the commercial license agreement existing since...
|
|
|
Gene Bridges Licenses Recombineering Technology to Chugai Pharmaceutical Co., Ltd
The Red/ET recombination technology, patented in Japan under the title 'Novel DNA Cloning Method, is a valued method for generating targeting vectors or modifying E.coli chromosomes. Red/ET is fast becoming the standard DNA...
|
|
|
Fertility doc says he implanted cloned human embryos
While none of the embryos Dr.Paniyiotis Zavos claims to have cloned resulted in a pregnancy, he said he'll continue trying. Cloning human embryos is not new; others have done so as part of stem cell research. But Zavos is the...
|
|
|
Human cloning claims condemned by leading scientists
A maverick fertility expert who claims to be able to clone human beings has been condemned by other scientists for unethical practices that would be likely to lead to a damaged baby if they succeeded at all.Panayiotis Zavos claims to have...
|
|
|
Cloning claims condemned by scientists
A maverick fertility expert who claims to be able to clone human beings has been condemned by other scientists for unethical practices that would be likely to lead to a damaged baby if they succeeded at all.Panayiotis Zavos claims to have...
|
